本文已被:浏览 1349次 下载 0次
中文摘要: 目的 了解洛阳市自1995—2018年发现并管理的所有患者的治疗情况和生存情况,探索影响治疗和生存的相关影响因素。方法 分析1995—2018年洛阳本地确证并管理的1 532例HIV感染者,计算病死率,用COX比例风险回归模型分析危险因素和生存时间的关系,用Kaplan-Meier绘制生存曲线,用logistic回归模型分析抗病毒治疗的影响因素。结果 1 532例HIV感染者共随访65160个月,其中168例在随访期内死亡,病死率为3.09%,接受抗病毒治疗的1 295例(85%),接受抗病毒治疗的病死率每年为1.74%,未接受抗病毒治疗的病死率每年为18.49%。没有抗病毒治疗、首次CD4检测结果小于200个/uL明显增加了HIV感染者的死亡风险。年龄段在60岁以下、在城市随访、主动检测、首次CD4检测结果小于200个/uL是更容易接受抗病毒治疗。结论 洛阳市HIV感染者病死率较北京、上海地区仍然较高,早发现和抗病毒治疗能够显著增加生存时间。应进一步加大宣传力度,扩大检测覆盖面,缩短从初筛到确证的时间,简化从确诊到服药的流程,推广“一站式服务”,最大限度地提高治疗率和随访率。
Abstract:OBJECTIVE To study the treatment and survival status of all patients found and managed in Luoyang from 1995 to 2018, and to explore the relevant influencing factors of treatment and survival. METHODS The data of 1532 HIV-infected persons confirmed and managed in Luoyang from 1995 to 2018 were collected, and the mortality rate was calculated. The relationship between risk factors and survival time were analyzed by COX proportional hazard regression model. The survival curve was drawn by Kaplan-Meier and the influencing factors of antiviral treatment were analyzed by Logistic regression model. RESULTS A total of 1 532 HIV-infected patients were followed up for 65 160 months. 168 of them died during the follow-up period. The mortality rate was 3.09/100 person-years. 1 295 cases(85%) received antiviral treatment. The mortality rate of patients receiving antiviral treatment was 1.74/100 person-years. The mortality rate of patients not receiving antiviral treatment was 18.49/100 person-years.Without antiviral treatment(ART), the first CD4 test was less than 200/uL, which significantly increased the risk of death of HIV-infected persons. It was easier to receive ART in urban follow-up, active detection, and the first CD4 test results less than 200/uL. CONCLUSION It showed that the mortality rate of HIV-infected people in Luoyang was still higher than Beijing and Shanghai. Early detection and ART could significantly increase the survival time. It should further strengthen publicity, expand the coverage of detection, shorten the time from primary screening to confirmation, simplify the process from confirmation to medication, promote “one-stop service” and maximize the treatment rate and follow-up rate.
keywords: AIDS survival analysis antiviral therapy
文章编号:3201911029 中图分类号:R1-9 文献标志码:
基金项目:
| 作者 | 单位 |
| 麻小龙①,朱 鑫①,李智军① |
| Author Name | Affiliation |
引用文本:
